Herman, J. L., Dornbos, P., Landheer, K., Geraghty, B. J., Egerman, M. A., Phan, D., Germino, M., Mastaitis, J. W., Walls, J. R., Lotta, L. A., Abecasis, G., Baras, A., Altarejos, J. Y., Sleeman, M. W., Melander, O., Shavlakadze, T., Yancopoulos, G. D., Bovijn, J., Marchini, J., Glass, D. J. (2026). Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity. Nature Communications. https://doi.org/10.1038/s41467-026-70422-2